Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.046x

Based on the latest financial reports, Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has a cash flow conversion efficiency ratio of 0.046x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥109.83 Million ≈ $16.07 Million USD) by net assets (CN¥2.41 Billion ≈ $352.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Shanghai Shenqi Pharmaceutical Investmen market cap and net worth for the company's overall valuation and market capitalisation.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A ranked by their cash flow conversion efficiency. Explore cash flow quality index of Shanghai Shenqi Pharmaceutical Investmen to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
SmartFinancial, Inc.
NASDAQ:SMBK
0.031x
Greene County Bancorp Inc
NASDAQ:GCBC
0.038x
Guangdong Banbao Toy Co Ltd
SHG:603398
-0.142x
Autohellas S.A.
AT:OTOEL
0.064x
Fujian Raynen Tech Co Ltd
SHG:603933
0.037x
Zhejiang Tieliu Clutch Co Ltd
SHG:603926
0.053x
Shanghai New World Co Ltd
SHG:600628
0.020x
Chularat Hospital Public Company Limited
BK:CHG-R
0.040x

Annual Cash Flow Conversion Efficiency for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1998–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A from 1998 to 2025. View Shanghai Shenqi Pharmaceutical Investmen stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥2.40 Billion
≈ $350.83 Million
CN¥124.47 Million
≈ $18.21 Million
0.052x -39.36%
2024-12-31 CN¥2.43 Billion
≈ $355.12 Million
CN¥207.79 Million
≈ $30.41 Million
0.086x -5.06%
2023-12-31 CN¥2.39 Billion
≈ $349.81 Million
CN¥215.59 Million
≈ $31.55 Million
0.090x -32.96%
2022-12-31 CN¥2.37 Billion
≈ $347.27 Million
CN¥319.23 Million
≈ $46.71 Million
0.135x +74.66%
2021-12-31 CN¥2.39 Billion
≈ $350.10 Million
CN¥184.26 Million
≈ $26.96 Million
0.077x +80.90%
2020-12-31 CN¥2.33 Billion
≈ $340.61 Million
CN¥99.10 Million
≈ $14.50 Million
0.043x -11.67%
2019-12-31 CN¥2.66 Billion
≈ $389.47 Million
CN¥128.28 Million
≈ $18.77 Million
0.048x -15.67%
2018-12-31 CN¥2.60 Billion
≈ $380.28 Million
CN¥148.53 Million
≈ $21.73 Million
0.057x +115.90%
2017-12-31 CN¥2.53 Billion
≈ $370.30 Million
CN¥66.99 Million
≈ $9.80 Million
0.026x +11200.00%
2016-12-31 CN¥2.43 Billion
≈ $356.31 Million
CN¥570.41K
≈ $83.47K
0.000x -98.22%
2015-12-31 CN¥2.29 Billion
≈ $334.49 Million
CN¥30.12 Million
≈ $4.41 Million
0.013x +405.40%
2014-12-31 CN¥2.00 Billion
≈ $292.37 Million
CN¥-8.62 Million
≈ $-1.26 Million
-0.004x -110.46%
2013-12-31 CN¥1.81 Billion
≈ $265.15 Million
CN¥74.75 Million
≈ $10.94 Million
0.041x +183.60%
2012-12-31 CN¥226.61 Million
≈ $33.16 Million
CN¥-11.18 Million
≈ $-1.64 Million
-0.049x -213.50%
2011-12-31 CN¥211.50 Million
≈ $30.95 Million
CN¥-3.33 Million
≈ $-487.11K
-0.016x -109.17%
2010-12-31 CN¥192.37 Million
≈ $28.15 Million
CN¥33.04 Million
≈ $4.83 Million
0.172x +309.61%
2009-12-31 CN¥183.43 Million
≈ $26.84 Million
CN¥7.69 Million
≈ $1.13 Million
0.042x -65.35%
2008-12-31 CN¥208.82 Million
≈ $30.56 Million
CN¥25.26 Million
≈ $3.70 Million
0.121x +54.40%
2007-12-31 CN¥204.29 Million
≈ $29.89 Million
CN¥16.01 Million
≈ $2.34 Million
0.078x +344.25%
2006-12-31 CN¥188.49 Million
≈ $27.58 Million
CN¥-6.05 Million
≈ $-884.87K
-0.032x -118.13%
2005-12-31 CN¥184.92 Million
≈ $27.06 Million
CN¥32.72 Million
≈ $4.79 Million
0.177x +528.48%
2004-12-31 CN¥176.21 Million
≈ $25.79 Million
CN¥4.96 Million
≈ $725.94K
0.028x -6.34%
2003-12-31 CN¥150.23 Million
≈ $21.98 Million
CN¥4.52 Million
≈ $660.84K
0.030x -72.58%
2002-12-31 CN¥146.14 Million
≈ $21.38 Million
CN¥16.02 Million
≈ $2.34 Million
0.110x +234.59%
2001-12-31 CN¥251.84 Million
≈ $36.85 Million
CN¥-20.51 Million
≈ $-3.00 Million
-0.081x -209.56%
2000-12-31 CN¥361.16 Million
≈ $52.85 Million
CN¥26.85 Million
≈ $3.93 Million
0.074x +864.07%
1999-12-31 CN¥336.74 Million
≈ $49.28 Million
CN¥-3.28 Million
≈ $-479.48K
-0.010x -104.86%
1998-12-31 CN¥363.26 Million
≈ $53.16 Million
CN¥72.67 Million
≈ $10.63 Million
0.200x --

About Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A

SHG:600613 China Drug Manufacturers - General
Market Cap
$589.87 Million
CN¥4.03 Billion CNY
Market Cap Rank
#11501 Global
#3254 in China
Share Price
CN¥8.41
Change (1 day)
-1.52%
52-Week Range
CN¥4.44 - CN¥12.40
All Time High
CN¥24.35
About

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fiel… Read more